We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Factory Location: 3 Block,No.333 Hanyang Road, Shizhong District, 641000, Neijiang City, Shizhong, China
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Payment Terms: T/T
Ingredients: Active ingredient: Palonosetron hydrochlorideExcipients: mannitol, edetic acid two, olivicic acid, plumic acid, hydrochloric acid, hydroxide, water for injection. Properties: This product is a colorless clear liquid. Indications: This product is suitable for adults:Prevention of acute nausea and vomiting caused by highly emetogenic chemotherapy.Prevention of acute and delayed nausea and vomiting caused by moderate emetic chemotherapy.Prevention of nausea and vomiting after surgery 24/J and within the hour.This product is suitable for patients under 1 month to 17 years of age:Prevention of acute nausea and vomiting caused by chemotherapy, including highly emetogenic chemotherapy. Dosage: Prevention of nausea and vomiting caused by chemotherapy:Adults: Intravenous palonosetron 0.25 mg approximately 30 minutes before the start of chemotherapy, which should be given for more than 30 seconds.Children (1 month to under 17 years): Intravenous palonosetron 20 μgl kg (maximum 1.5 mg) approximately 30 minutes before the start of chemotherapy should be given for more than 15 minutes.Prevention of nausea and vomiting after surgery:The recommended dose is: Palonosetron 0.075 mg intravenously immediately before induction of anesthesia for more than 10 seconds.The concentration of this product is 0.05mg/mL and can be administered directly intravenously.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
